Article
Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.
Diabetes care - 1 Sept 2003
Roguin Ariel, Koch Werner, Kastrati Adnan, Aronson Doron, Schomig Albert, Levy Andrew P
Abstract excerpt
OBJECTIVE: The goal of this study was to determine whether the haptoglobin (Hp) genotype was predictive of restenosis and major adverse cardiac events (MACEs) after percutaneous transluminal coronary angioplasty (PTCA) in individuals with diabetes. RESEARCH DESIGN AND METHODS: A consecutive series of 935 diabetic patients treated with oral agents and/or insulin were followed for 1 year after PTCA. The primary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.